Rigel Pharmaceuticals financial statements

라이절 파머슈티컬스NASDAQ:RIGL · Nasdaq · Healthcare · sector #16
$46.11-3.52%
2026-10-06 close · prelim

Rigel Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $179M. 2024 operating profit was $24M.

Reported results

Rigel Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q